Strategic Acquisition LiNA Medical recently expanded through the acquisition of UroCure, a Minneapolis-based medical device company, signaling a strategy to broaden offerings in female stress urinary incontinence and accelerate access to new markets and regulatory approvals.

Urology Cross-Sell The combined portfolio includes sling systems for female stress urinary incontinence, presenting a clear cross-sell opportunity to customers already deployed with LiNA gynecologic devices and to UroCure customers expanding into urinary incontinence solutions.

Geographic Expansion Recent launches and nationwide activations in Minnesota and Georgia for ArcSP and ArcTO systems indicate momentum in the US market; potential to scale sales through distributor networks and direct sales in additional states.

Out-of-the-box Advantage Emphasize LiNA’s ready-to-use, simple-to-operate devices designed with healthcare professional collaboration, aligning with customers seeking efficient adoption and minimal training for fast time-to-value in operating rooms.

Digital & Analytics Utilize LiNA’s tech stack and data-driven tools (Power BI, Google Ads, Dynamics, Intercom) to optimize targeted marketing to female health specialists, track adoption of new sling systems, and identify high-potential accounts for upsell opportunities.